191 related articles for article (PubMed ID: 35192432)
1. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma.
Dong Z; Chang X; Xie L; Wang Y; Hou Y
Bioengineered; 2022 Mar; 13(3):6100-6112. PubMed ID: 35192432
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma.
Huang Y; Wu Q; Tan X
Bioengineered; 2022 Mar; 13(3):6955-6965. PubMed ID: 35249447
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
Lin Q; Jiang Y; Zhou F; Zhang Y
Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
[TBL] [Abstract][Full Text] [Related]
5. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC.
Song J; Ye A; Jiang E; Yin X; Chen Z; Bai G; Zhou Y; Liu J
J Cell Biochem; 2018 Aug; 119(8):6665-6673. PubMed ID: 29741786
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma.
Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ
Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
8. Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis.
Duggan WP; O'Connell E; Prehn JHM; Burke JP
Mol Cell Biochem; 2022 Oct; 477(10):2451-2467. PubMed ID: 35583632
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
[No Abstract] [Full Text] [Related]
10. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
Jia Q; Wang H; Xiao X; Sun Y; Tan X; Chai J; Yang Y; Yin Z; Li M; Wang K; Liu J
Pathol Res Pract; 2023 Jul; 247():154574. PubMed ID: 37257242
[TBL] [Abstract][Full Text] [Related]
11. The crucial role of SRPK1 in TGF-β-induced proliferation and apoptosis in the esophageal squamous cell carcinomas.
Ren G; Sheng L; Liu H; Sun Y; An Y; Li Y
Med Oncol; 2015 Jul; 32(7):209. PubMed ID: 26099172
[TBL] [Abstract][Full Text] [Related]
12. The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.
Ding H; Xiong XX; Fan GL; Yi YX; Chen YR; Wang JT; Zhang W
Biomed Res Int; 2020; 2020():5478574. PubMed ID: 32351997
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract][Full Text] [Related]
14. Serine-arginine protein kinase 1 is associated with hepatocellular carcinoma progression and poor patient survival.
Zhang J; Jiang H; Xia W; Jiang Y; Tan X; Liu P; Jia H; Yang X; Shen G
Tumour Biol; 2016 Jan; 37(1):283-90. PubMed ID: 26201897
[TBL] [Abstract][Full Text] [Related]
15. Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes.
Liu M; Wei D; Nie Q; Peng L; He L; Cui Y; Ye Y
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):663-671. PubMed ID: 35779918
[TBL] [Abstract][Full Text] [Related]
16. Serine-arginine protein kinase 1 is associated with breast cancer progression and poor patient survival.
Li XH; Song JW; Liu JL; Wu S; Wang LS; Gong LY; Lin X
Med Oncol; 2014 Aug; 31(8):83. PubMed ID: 24961466
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Serine-Arginine Protein Kinase 1 Inhibits the Growth and Migration in Renal Cell Carcinoma Cells.
Han X; Yang J; Jia Z; Wei P; Zhang H; Lv W; Sun J; Huo Q
Oncol Res; 2017 Mar; 25(3):389-395. PubMed ID: 27662590
[TBL] [Abstract][Full Text] [Related]
18. DGUOK-AS1 promotes cervical squamous cell carcinoma progression by suppressing miR-499a-5p that targets SPRR1B in vitro.
Song Y; Pan H; Yang L; Fan Y; Zhang H; Pan M; Zhang Y
Biochem Biophys Res Commun; 2021 Dec; 585():177-184. PubMed ID: 34808501
[TBL] [Abstract][Full Text] [Related]
19. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract][Full Text] [Related]
20. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives.
Nikas IP; Themistocleous SC; Paschou SA; Tsamis KI; Ryu HS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
